Dongwoo Pharm. Co., Ltd.

Company Description

Dongwoo Pharm. Co., Ltd.,Dongwoo, have started our business from 1994 as a stock seller in fields of pharmaceutical raw materials in Korea and doing business with many Korean pharmaceutical manufacturing companies at this time.

For the supplying of more good quality products to our customers, we established Dongwoo Syntech Co., Ltd. as a API synthetic company in 2000 and approved BGMP facilities by Korea FDA in 2002.

As the results of our steady efforts for the developing and researching, Dongwoo Syntech Co., Ltd. was approved 10 products as K-DMF products by Korea FDA and now, producing and supplying good API products about 30 items to local customers and overseas affiliates companies.

Also, Dongwoo Syntech Co., Ltd. was certified as a 'Good Technology Company' and 'Innovation Business Company' by Korea government authorities recently.

Dongwoo Syntech is proceeding to register European DMF for Glimepiride, Propiverine HCl and Gemcitabine HCl in order to launch to EU and South America market and concurrently, developing several products for Japanese market.

Especially, we are doing our best efforts to develop Oncology products at this moment and have planning to establish an exclusive manufacturing factory(API manufacturing site) for these products in the near future.

We, Dongwoo are always ready to discuss with you for the contract manufacturing as well as commercial API business as your good partner and hope to create bright future together.